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Abstract
Background: Caspase-12 functions as an antiinflammatory enzyme inhibiting caspase-1 and the NOD2/RIP2 pathways. Due
to increased susceptibility to sepsis in individuals with functional caspase-12, an early-stop mutation leading to the loss of
caspase-12 has replaced the ancient genotype in Eurasia and a significant proportion of individuals from African
populations. In African-Americans, it has been shown that caspase-12 inhibits the pro-inflammatory cytokine production.
Methodology/Principal Findings: We assessed whether similar mechanisms are present in African individuals, and whether
evolutionary pressures due to plague may have led to the present caspase-12 genotype population frequencies. No
difference in cytokine induction through the caspase-1 and/or NOD2/RIP2 pathways was observed in two independent
African populations, among individuals with either an intact or absent caspase-12. In addition, stimulations with Yersinia
pestis and two other species of Yersinia were preformed to investigate whether caspase-12 modulates the inflammatory
reaction induced by Yersinia. We found that caspase-12 did not modulate cytokine production induced by Yersinia spp.
Conclusions: Our experiments demonstrate for the first time the involvement of the NOD2/RIP2 pathway for recognition of
Yersinia. However, caspase-12 does not modulate innate host defense against Y. pestis and alternative explanations for the
geographical distribution of caspase-12 should be sought.
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Introduction
Caspases are cysteine proteases that are involved in apoptosis and
inflammation [1–3]. Three human caspases involved in the
inflammation pathway are known, namely caspase-1, 4, and 5 [2,3].
In other mammals such as mice and chimpanzees, another caspase
with modulatory effects on inflammation is caspase-12. In humans, a
truncated non-functional form of caspase-12 due to a mutation
resulting in an early stop codon has largely replaced the ancient
genotype [4]. Genetic and population analysis revealed that the
functional form of caspase-12 is present in 20 to 30% of the African
populations, while completely absent in Europe and Asia [5,6]. Due to
this particular worldwide distribution and its involvement in
inflammation, caspase-12 has been proposed as an exquisite example
of an immune gene changed under evolutionary pressure.
Functionally, caspase-12 has been reported to be involved both
in the apoptotic and inflammatory pathways [7]. Whole blood
stimulation with lipopolysaccharide (LPS) showed that individuals
bearing the functional caspase-12 were hypo-responsive. LPS, an
outer cellular membrane structure found on Gram-negative
bacteria is recognized by our innate immune system [8]. The
innate immune system recognizes specific pathogen structures,
such as LPS through pattern recognition receptors (PRR) like toll-
like receptors (TLRs) [9]. TLR4 is the most important PRR
involved in the recognition of LPS, TLR2 recognizes bacterial
lipopeptides, and the NOD2 receptor recognizes peptidoglycans.
PRR engagement induces production of proinflammatory cyto-
kines such as TNF-a and IL-1b. The IL-1b activation requires
cleavage by another inflammatory caspase termed IL-1b convert-
ing enzyme or caspase-1 [10].
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produced lower TNF-a and IL-1b levels compared to individuals
bearing only the truncated form of caspase-12 [11]. It has been
therefore proposed that caspase-12 has anti-inflammatory effects
by inhibiting both the NFkB and caspase-1 pathways [12]. As a
consequence of the altered NFkB and caspase-1 pathway
stimulation in individuals bearing functional caspase-12, the
clearance of Gram-negative bacteria may be defective and
eventually this could result in a life threatening bacterial infection
[13,14]. A small clinical study among African Americans showed
that the pressure of a functional caspase-12 was accompanied by
an increased susceptibility to sepsis [15]. These findings were
supported by a sepsis mouse model showing that caspase-12 mice
had a higher bacterial count and lower pro-inflammatory cytokine
production during sepsis [11].
Evolutionary studies [6,16] determined that the loss of
functional caspase-12 in Caucasian and Asian populations was
caused by recent positive selection. The loss of function of caspase-
12 is due to truncation of the protein, rather then modulation of
mRNA transcription. These data combined with the correlation of
caspase-12 with susceptibility to sepsis, lead to the hypothesis that
the loss of functional caspase-12 was due to the increasing pressure
of sepsis during the human migration towards Europe and Asia
[6]. After blood stimulation of individuals bearing the functional
and non-functional caspase-12 with LPS it was shown that the
non-functional caspase-12 protein was not transcriped [11]. This
indicates that early stop codon results in a loss of function of the
caspase-12. However, the assumption that the loss of function of
capase-12 involved in the innate immune response are based on a
single study in a small number of African Americans, but no data
on the function of caspase-12 in African populations are available
[16].
This is essential for the understanding of how the selection has
driven selection of caspase-12 genotypes during human history. In
the present study we assessed the impact of caspase-12 genotypes
on inflammation in two African populations, and the potential
effect of caspase-12 on a microorganism known to have exerted
intense evolutionary pressure on European and Asian populations:
Yersinia pestis, the agent of bubonic plague.
Results
Functional and non-functional caspase-12 frequencies in
Mali volunteers
To evaluate the effect of non-functional and functional caspase-
12 genotypes on proinflammatory cytokines, blood was initially
collected from 50 healthy Mali volunteers. Thirthy-three of the
volunteers were homozygous (66%) for the non-functional caspase-
12 allele, 16 volunteers were heterozygous (32%), and one (2%)
was homozygous for the functional caspase-12 allele (Table 1).
These frequencies of the caspase-12 genotypes were in line with
previous reports [5].
Pro-inflammatory cytokine production of the caspase-12
genotypes
Stimulation of whole blood was performed with either the
TLR4 ligand LPS (concentrations 1, 10 and 100 ng/ml) or
Pam3Cys (10 mg/ml), a TLR2 specific ligand. Similar levels of
TNF-a between caspase-12 genotypes were observed between the
groups (Figure 1A). Surprisingly, the IL-1b production was even
increased in individuals heterozygous for the functional caspase-12
allele, for all LPS concentrations tested (Mann-Whitney, P,0.05,
figure 1B). In addition, the individual homozygous for the
functional caspase-12 allele showed no evidence of inhibition of
the production of pro-inflammatory cytokines (Figure 1). The
release of the anti-inflammatory cytokine IL-10 was independent
of the caspase-12 genotype (Figure 1C).
Replication within second field study of previous findings
Because the result of our initial study clearly contradicted one
earlier report of inhibition of the pro-inflammatory response by
caspase-12, we initiated a second field study to assess the function
of caspase-12 [11]. During this second study we collected blood
from 47 Mali volunteers and determined their caspase-12
genotype (volunteers 2007, Table 1). Twenty-four individuals
were homozygous (51%) for the non-functional caspase-12 allele,
22 heterozygous (47%), and one volunteer was homozygous (2%)
for the functional caspase-12 allele (Table 1). No difference was
found between cells isolated from individuals homozygous for the
non-functional caspase-12 allele and from the heterozygous
volunteers, when production of TNF-a, IL-1b or IL-10 was
measured (Figure 2). No differences for the production of IL-1b
were found between the groups in this second study. The cytokine
production of cells isolated from the volunteer homozygous for the
functional caspase-12 was comparable with the other genotypes
(Figure 2 B and C).
Yersinia spp stimulations
Stimulation with pure TLR4 (LPS) and TLR2 (Pam3Cys)
ligands showed no anti-inflammatory role of the functional
caspase-12. The lack of inhibition could have been caused by
the specific TLR stimuli used in these experiments. Therefore,
whole blood from the second volunteer cohort was also stimulated
with three pathogenic Yersinia species, namely Y. enterocolitica, Y.
pseudotuberculosis and Y. pestis (Figure 3). These three Yersinia spp
were chosen due to their important role as human pathogens.
With all three Yersinia species no different pro-inflammatory
cytokine production was observed between the functional and
non-functional caspase-12 individuals (Figure 3). This indicates
Table 1. Caspase-12 genotypes and allele frequency in two cohorts of Mali volunteers, one collected in 2006 and one in 2007.
Non-functional Functional Functional Genotype frequency (%) Allele frequency
TGA S/S (T/C)GA S/L CGA L/L Total T/T C/T C/C T C
2006
a 33 16 1 50 66.00 32.00 2.00 0.82 0.18
2007
a 24 22 1 47 51.06 46.81 2.13 0.74 0.26
Total
a,b 57 38 2 97 58.76 39.18 2.06 0.78 0.22
aPopulation do not violate Hardy-Weinberg equilibrium.
bDistribution of Caspase-12 genotypes between 2006 and 2007 populations did not differ (x
2-test).
doi:10.1371/journal.pone.0006870.t001
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caspase-12.
NOD2/RIP2 pathway
Beside the caspase-1 pathway it has been shown that caspase-12
inhibition of the NOD2/RIP2 pathway is important for the lower
pro-inflammatory cytokine release[17]. To test if the NOD2/RIP2
pathway was involved in the innate immune response against Yersinia
spp. we preformed stimulations with the same three Yersinia spp. in
cells isolated from individuals homozygous for the 3020insC NOD2
mutation (Figure 4). It was observed that the individuals homozygous
for the 3020insC NOD2 mutation display a tendency towards
reduced TNF-a production (Figure 4A) and a significant lower IL1-b
production after stimulation with all three Yersinia spp (Figure 4B).
This demonstrates that the NOD2 receptor does play an important
role in Yersinia recognition by the innate immune system. Secondly,
involvement of the NOD2/RIP2 pathway during Yersinia spp
recognition also indicates that if functional caspase-12 would have
inhibited the pro-inflammatory response through the NOD2/RIP2
pathway, a reduction in IL-1b production induced by Yersinia would
have been expected, and that was not the case (Figure 3B).
Discussion
Caspase-12 is a member of the caspase family of cysteine
proteases that has been suggested to exert inhibitory effects on
proinflammatory cytokines. The only populations that retain a
Figure 1. In-vitro cytokine measurements after whole blood LPS and Pam3Cys stimulation between the caspase-12 genotypes from
the volunteers enrolled in 2006. Stimulation was performed with 1, 10 and 100 ng/ml LPS (E. coli) and 10 mg/ml Pam3Cys. TNF (A), IL-1b (B) and
IL-10 (C) were measured by ELISA in the supernatant after 24 hour stimulation. Volunteers were grouped as homozygous bearing the nonfunctional
caspase-12 genotype (S/S), heterozygous bearing the nonfunctional and functional caspase-12 (S/L), and homozygous bearing the functional
caspase-12 (L/L). Numbers of volunteers included for each cytokine are S/S=33, S/L=16 and L/L=1. Values represent mean + SD for each group of
volunteers. P-values for differences between caspase-12 genotype were calculated with the Mann-Whitney test. *P,0.05.
doi:10.1371/journal.pone.0006870.g001
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in Sub-Saharan Africa. The aim of the present study was to assess
the effect of caspase-12 on the cytokine response of cells isolated
from volunteers of African origin, after stimulation with bacterial
stimuli. These experiments revealed that functional caspase-12
had no inhibitory effect on the pro-inflammatory response
(Figure 1). In a small previous study performed in cells isolated
from 18 African Americans (eight homozygous for the non-
functional allele, eight heterozygous, two homozygous for the
functional caspase-12), Saleh et al suggested that a functional
caspase-12 decreased cytokine production [11;15].
Becauseourdatafromthefirstfieldstudyclearlydiffered fromthis
previous investigations we repeated our experiments in cells isolated
from volunteers froma second independent African population from
the same region (Table 1, Figure 2). The results from the second
study support the conclusion that caspase-12 had no modulatory
effect on the TLR-stimulated production of cytokines.
In the first cohortof volunteers, we did observed an elevated IL-1b
production in individuals with an active caspase-12. Interestingly, in a
colonic inflammation mouse model Leblanc et al also found that mice
with a functional caspase-12 had a higher production of pro-
inflammatory cytokine on day 14, although no differences in the
production of the pro-inflammatory cytokines were observed early in
the process [17]. However, this effect on IL-1b production could not
be reproduced in the second field study. Therefore, the overall
conclusion of these two studies must be that caspase-12 is unlikely
Figure 2. In-vitro cytokine measurements after whole blood LPS and Pam3Cys stimulation between the caspase-12 genotypes from
the volunteers enrolled in 2007. Stimulation with LPS was performed with 10 ng/ml. TNF (A), IL-1b (B) and IL-10 (C) were measured by ELISA after
24-hour stimulation. Volunteers were grouped as homozygous bearing the nonfunctional caspase-12 genotype (S/S), heterozygous bearing the
nonfunctional and functional caspase-12 (S/L) and homozygous that bear the functional caspase-12 (L/L). Numbers of volunteers included for each
cytokine are S/S=24, S/L=22 and L/L=1. Values represent mean + SD for each group of volunteers. P-values for differences between caspase-12
genotype were calculated with the Mann-Whitney test.
doi:10.1371/journal.pone.0006870.g002
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induced by LPS or bacterial lipopeptides.
Our first set of experiments used specific TLR4 and TLR2
ligands to elicit inflammation. However, bacterial pathogens are
much more complex structures, and an effect of caspase-12 during
stimulation with intact microorganisms could still be envisaged. In
support of this hypothesis, it has been reported that individuals with
a functional caspase-12 are more susceptible to sepsis [11].
Therefore, we wanted to assess whether stimulation of cells with
various caspase-12 genotypes with complex Gram-negative micro-
organismsresulted indifferencesinpro-inflammatory cytokines.We
performed stimulations with the Gram-negative bacteria Y. pestis,
the agent of bubonic plague, an infection that is well-known to have
induced an important evolutionary pressure on Europe and Asian
Figure 3. In-vitro cytokine measurements after whole blood stimulation with Yersinia enterocolitica, Yersinia pseudotuberculosis and
Yersinia pestis. TNF (A), IL-1b (B) and IL-10 (C) were measured by ELISA after 24-hour stimulation. Volunteers were grouped as homozygous bearing
the nonfunctional caspase-12 genotype (S/S), heterozygous bearing the functional caspase-12 and nonfunctional (S/L) and homozygous that bear
the functional caspase-12 (L/L). The numbers of volunteers included for each cytokine are S/S=24, S/L=22 and L/L=1. Values represent mean + SD
for each group of volunteers. P-values for differences between caspase-12 genotype were calculated with the Mann-Whitney test.
doi:10.1371/journal.pone.0006870.g003
Caspase-12 and Y. pestis
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Y. enterocolitica, an important pathogene of the digestive tract, and
with Y. pseudotuberculosis the recent ancestor of Y. pestis [18]. Previous
studies have shown the role of TLR2 and TLR4 for Y. pestis
recognition [19]. In our stimulation of individuals with the
homozygote 3020insC NOD2 mutation we demonstrate the
involvement of the NOD2 pathway during Yersinia spp recognition
(Figure 4). The fact that both TLR and NOD2 pathways have been
proposed to be modulated by caspase-12, makes Yersinia therefore
the ideal bacterial model for the assessment of caspase-12 effects.
Important in the recognition of Yersinia strains is the recognition
through TLR4. Montminy et al. showed that Y. pestis actively
changes its LPS structure after the transmission to humans [20].
By doing this, Y. pestis actively avoids TLR4 recognition and the
innate immune response necessary for the clearance. Yersinia also
manipulates the innate immune system of hosts with a mechanism
known as the type III secretion system [21]. Hereby Yop proteins
are secreted and interfere with the inflammation response. These
proteins take control of host cells by inhibiting the caspase-1-
mediated maturation and IL-1b release [22]. This indicates that
both NFkB and caspase-1 signaling pathways are involved in the
recognition of Yersinia. However, our experiments performed in a
large number of volunteers bearing a functional caspase-12 do not
show any modulation of Yersinia-induced cytokines, and thus of the
TLR/NOD2 pathways.
Earlier studies on the distribution of caspase-12 genotypes have
shown important differences between populations [5;6], but it is
unclear how environmental pressure caused selection of certain
alleles, and lead to loss of caspase-12 function in the majority of
individuals [23]. Our study in two African populations does not
support a role for caspase-12 in the modulation of the pro-
inflammatory response after TLR challenge. Similarly, no effect of
caspase-12 on Yersinia stimulation of cytokines was observed.
Phylogenetic analyses show that structurally, caspase-12 is grouped
with the other inflammatory caspases, but the potential mecha-
nisms through which caspase-12 potentially modulate the
inflammation are still not well understood [24;25]. Most data
available to date have been obtained in mice defective in caspase-
12, that showed a higher cytokine response and increased
resistance in bacterial models [15;17]. These data seem to be
supported by a small study in humans, suggesting high cytokine
responses in humans with inactive caspase-12 [11]. Unfortunately,
this study has not been independently confirmed and seem to be
contradicted by our data. The cause of the differences between the
study of Saleh and colleagues and the present study are unclear. In
our study we have performed a dose-response curve of LPS
Figure 4. In-vitro cytokine measurements after PBMC stimulation with Yersinia enterocolitica, Yersinia pseudotuberculosis and Yersinia
pestis. Caucasian individuals bearing a normal (NOD2 wt, N=10) or homozygous for the 3020insC NOD2 mutation (NOD2 del, N=5) were stimulated
with the various Yersinia spp. TNF (A) and IL-1b (B) were measured by ELISA after 24-hour stimulation. Values represent mean + SD for each group of
volunteers. P-values for differences between caspase-12 genotype were calculated with the Mann-Whitney test. *P,0.05, **P#0.01.
doi:10.1371/journal.pone.0006870.g004
Caspase-12 and Y. pestis
PLoS ONE | www.plosone.org 6 September 2009 | Volume 4 | Issue 9 | e6870concentrations (Figure 1), and therefore it is unlikely that
differences in LPS concentrations could explain the discrepancy.
We have also preformed the experiments in a larger numbers of
individuals than the original study of Saleh et al, and the results
were verified in a second cohort. Ethnic differences between the
African American volunteers in the study of Saleh et al and the
Mali population investigated in our study could account for some
differences, although the theoretic basis for this is unclear. The
only additional study investigating the role of caspase-12 in
infections found no correlation between caspase-12 and hepatitis
C virus infection [26]. It is possible that caspase-12 may interact
also with other PRRs than TLR4 and NOD2. However, by using
whole microorganisms as Yersinia spp., that very likely stimulates
also TLR2, TLR5, TLR9 (etc), we practically exclude an influence
of caspase-12 on other important PRR pathways as well.
In summary, the data of the present study show no regulatory
role of human caspase-12 on the inflammation induced by TLR
ligands or Yersinia spp. Although a role of caspase-12 for the
susceptibility to sepsis can still be envisaged (which has to be
confirmed in larger studies), this is highly unlikely to be mediated
through modulation of cytokine response. Alternatively, the
selection found in European and Asian populations on the non-
functional caspase-12 may have not been caused by sepsis at all,
and other biological explanations should be sought.
Materials and Methods
Volunteers
Blood samples were collected in the Koro district of Mali, West
Africa during two fieldtrips in September 2006 and April 2007.
These studies are part of the investigational into interethnic
differences in susceptibility to malaria, as described in detail
elsewhere [27]. From these volunteers we only included the
healthy individuals without any suspicion or diagnosis for malaria.
Approval for the study was provided by the institutional review
board of the University of Bamako (Nu0527/FMPOS).
A total of 10 Dutch Caucasian controls and 5 Dutch Caucasian
volunteers homozygous for the loss-of-function 3020insC NOD2
mutation were used for the stimulation experiments investigating
the role of NOD2 in the recognition of Yersinia. The characteristics
of the NOD2-defective individuals are described elsewhere [28].
Cytokine stimulation assays
Venous whole blood was collected into 10 ml heparin tubes
(BD, Plymouth, UK) Blood from healthy individuals was diluted to
a final concentration of 1:5 in RPMI 1640 medium (containing
1% glutamine, 1% pyruvate and 1% gentamicin). Stimulation was
performed with control medium, highly purified lipopolysaccha-
ride (Escherichia colli 055:B5, sigma, extra purified according to
Hirshfeld et al. [29]) at various concentrations (1, 10 and 100 ng/
ml), and the lipopeptide Pam3Cys (10 mg/ml, EMC Microcollec-
tions, Erlaugen). Heat-Killed Yersinia enterocolitica (clinical isolated),
Yersinia pseudotuberculosis, serotype O1 (strain YERS0068) and
Yersinia pestis antiqua, biovar Antiqua (strain BD94-oo544), were
used for the stimulation experiments at a final concentration of
1610
4/ml. Yersinia strains were cultured in BHI-broth (Tritium,
Eindhoven, The Netherlands) for 48 hours at 37uC. The cells were
resuspended in milliQ and heat treated at 95uC for 30 minutes.
Colony forming units (CFU) and loss of viability of the cells after
heat treatment were determined by plating appropriate dilutions
on blood agar (Biotrading, Mijndrecht, The Netherlands) followed
by incubation at 37uC for 48 hours. After 24 hours of stimulation
at 37uC, supernatants were collected and stored at 280uC until
cytokines measurements were preformed.
For the stimulations of cells isolated from the NOD2-defective
individuals, peripheral blood mononuclear cells (PBMCs) were
isolated by density gradient centrifugation on Ficoll, washed three
times in cold RPMI, counted and resuspended in complete culture
medium. PBMCs (final concentration 2.5610
6/ml) were stimu-
lated with three Yersinia strains in 96-well round-bottom plates for
24 hours at 37uC. After stimulation, supernatants were collected
and directly used for cytokine measurement.
Cytokine measurements
IL-10 and IL1-b cytokine concentrations were measured by
sandwich ELISA (Sanquin, Amsterdam, The Netherlands). TNF-a
production was measured by a specific ELISA, as previously
described [30].
Caspase-12 genotypic determination
DNA for all volunteers was extracted from whole blood using
the Puregene (Gentra Systems, Minneapolis, MN) isolation kit.
Flanking primers of the surrounding T125C polymorphism region
and methodology was adopted as described by Saleh et al[11].
Sequencing was performed at the sequence faculty at the
department of human genetics Nijmegen on the 48-capillary
3730 sequencer (Applied Biosystems). Genotypes of the volunteers
were analyzed and determined using the software 4Peaks by A.
Griekspoor and T. Groothuis (mekentosj.com).
Statistical analysis
Data were analysed in SPSS (Rel.16; SPSS, Chicago, IL).
Genotypic distribution between 2006 and 2007 was assessed by x
2-
test. Differences in cytokine response to the stimuli between groups
were analysed by Mann-Whitney. P-values,0.05 were considered
statistically significant in all analysis.
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